US Broker Ratings

Autolus Therapeutics plc (AUTL) Stock Analysis: Exploring a 407% Potential Upside in Biotech

Autolus Therapeutics plc (AUTL) presents a compelling opportunity for investors eyeing the biotechnology sector, particularly those interested in innovative cancer therapies. With a market capitalization of..

Simulations Plus, Inc. (SLP) Stock Analysis: Is There Value in Stability with a $374 Million Market Cap?

Simulations Plus, Inc. (NASDAQ: SLP), a stalwart in the healthcare sector focusing on health information services, has long been a pivotal player in the development of..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Neuropace, Inc. (NPCE) Stock Analysis: Navigating a 56% Potential Upside with Healthcare Innovation

Investors eyeing the healthcare sector might want to take a closer look at Neuropace, Inc. (NASDAQ: NPCE), a promising player in the medical device industry. With..

Personalis, Inc. (PSNL) Investor Outlook: Navigating the Path with Strong Revenue Growth Amid Valuation Challenges

Personalis, Inc. (NASDAQ: PSNL), a rising entity in the healthcare sector, primarily operates within the diagnostics and research industry. Based in Fremont, California, this company has..

Orthofix Medical Inc. (OFIX) Stock Analysis: Assessing a 35% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the medical technology industry, has been garnering attention from investors, particularly in the healthcare sector. With a..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a 69.48% Potential Upside Amid Strong Buy Ratings

For investors eyeing the biotechnology sector, Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) presents a compelling case with a remarkable potential upside of 69.48%, driven by its strategic..

LifeMD, Inc. (LFMD) Stock Analysis: Unpacking a 230% Potential Upside in the Telehealth Sector

LifeMD, Inc. (LFMD), a burgeoning player in the healthcare sector, is carving out a niche in the health information services industry with its innovative direct-to-patient telehealth..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: A Potential 80% Upside Beckons Investors

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, presents a compelling opportunity for investors seeking exposure in the healthcare industry. With..

COMPASS Pathways Plc (CMPS): Analyst Ratings Highlight 104% Upside Potential in Revolutionary Mental Health Treatments

For investors seeking opportunities in the healthcare sector, COMPASS Pathways Plc (NASDAQ: CMPS) presents a compelling case with its focus on innovative mental health therapies. Based..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring the 94.53% Potential Upside in Biotechnology

Arvinas, Inc. (NASDAQ: ARVN) stands out in the biotechnology sector with a market capitalization of $468.17 million. As a clinical-stage biotechnology company, Arvinas is at the..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Evaluating Growth Potential Amid Challenging Metrics

Fortrea Holdings Inc. (NASDAQ: FTRE), a prominent player in the biotechnology sector, is attracting attention from investors with its positioning as a contract research organization. Specializing..

LENZ Therapeutics (LENZ) Stock Analysis: Exploring a 568% Potential Upside in Biotechnology

LENZ Therapeutics, Inc. (NASDAQ: LENZ) has emerged as a compelling entity within the biotechnology sector, attracting significant attention from investors and analysts alike. Specializing in the..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Biotech Opportunity with 233% Upside Potential

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has emerged as a compelling prospect in the biotechnology sector, drawing attention from investors due to its innovative approach in developing..

Verastem, Inc. (VSTM) Stock Analysis: Biotech Firm Poised for 86% Upside with Strong Buy Ratings

Verastem, Inc. (NASDAQ: VSTM) has emerged as a compelling player in the biotechnology sector, capturing investor attention with its robust pipeline targeting cancer therapies and an..

Talkspace, Inc. (TALK) Stock Analysis: A Healthcare Innovator with 21.43% Potential Upside

Talkspace, Inc. (NASDAQ: TALK), a pioneer in the virtual behavioral healthcare sector, has been making waves in the health information services industry. With a market capitalization..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Unveiling an 88.79% Potential Upside in Biotechnology

In the dynamic world of biotechnology, Stoke Therapeutics, Inc. (NASDAQ: STOK) stands out as a promising player, capturing investor attention with its innovative approach to treating..

Zenas BioPharma, Inc. (ZBIO): Investor Outlook Reveals 88.48% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a prominent player in the biotechnology sector, is drawing investor attention with its promising potential upside of 88.48%. Headquartered in Waltham,..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unpacking a 271% Potential Upside in the Biotech Sector

Capricor Therapeutics, Inc. (NASDAQ: CAPR) stands at a fascinating crossroads within the biotechnology sector, offering investors a compelling opportunity characterized by significant potential upside. With a..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Stability and Strategic Positioning in the Biotech Sector

KalVista Pharmaceuticals, Inc. (KALV), a key player in the biotechnology sector, presents a unique investment case that stands apart in today’s volatile market landscape. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds